Cannabics Pharmaceuticals Stock Return On Equity
CNBX Stock | USD 0.01 0.00 0.00% |
Cannabics Pharmaceuticals fundamentals help investors to digest information that contributes to Cannabics Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Cannabics OTC Stock. The fundamental analysis module provides a way to measure Cannabics Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabics Pharmaceuticals otc stock.
Cannabics |
Cannabics Pharmaceuticals OTC Stock Return On Equity Analysis
Cannabics Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Cannabics Pharmaceuticals Return On Equity | -42.89 |
Most of Cannabics Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabics Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Cannabics Pharmaceuticals has a Return On Equity of -42.8936. This is 78.95% higher than that of the Pharmaceuticals sector and 17.65% higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Cannabics Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannabics Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cannabics Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cannabics Pharmaceuticals by comparing valuation metrics of similar companies.Cannabics Pharmaceuticals is currently under evaluation in return on equity category among related companies.
Cannabics Fundamentals
Return On Equity | -42.89 | |||
Return On Asset | -1.0 | |||
Current Valuation | 6.67 M | |||
Shares Outstanding | 1.26 M | |||
Shares Owned By Insiders | 57.59 % | |||
Price To Earning | 31.09 X | |||
Price To Book | 20.39 X | |||
Price To Sales | 7,566 X | |||
Gross Profit | 7.16 K | |||
EBITDA | (3.52 M) | |||
Net Income | (3.72 M) | |||
Cash And Equivalents | 96.28 K | |||
Cash Per Share | 0.08 X | |||
Total Debt | 1.6 M | |||
Debt To Equity | 0.48 % | |||
Current Ratio | 0.11 X | |||
Book Value Per Share | (1.57) X | |||
Cash Flow From Operations | (1.68 M) | |||
Earnings Per Share | (3.80) X | |||
Beta | 1.52 | |||
Market Capitalization | 123.28 K | |||
Total Asset | 811.17 K | |||
Z Score | -13.2 | |||
Net Asset | 811.17 K |
About Cannabics Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabics Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabics Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabics Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Cannabics Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cannabics Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabics Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cannabics Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cannabics Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cannabics Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cannabics Pharmaceuticals to buy it.
The correlation of Cannabics Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cannabics Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cannabics Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cannabics Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cannabics Pharmaceuticals. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Cannabics Pharmaceuticals information on this page should be used as a complementary analysis to other Cannabics Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Cannabics OTC Stock analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |